Tranzyme financial update

Tranzyme established an at-the-market program to sell up to $25 million of its common stock. Cowen is the sales agent.

Separately, Tranzyme filed a shelf registration covering the sale of up to $100 million of its securities. The company, which closed Friday at $2.77 has 24.6 million shares outstanding. ...